• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对帕金森病中的胆碱能系统。

Targeting the cholinergic system in Parkinson's disease.

机构信息

Department of Neurobiology, Harvard Medical School, Boston, 02115, MA, USA.

出版信息

Acta Pharmacol Sin. 2020 Apr;41(4):453-463. doi: 10.1038/s41401-020-0380-z. Epub 2020 Mar 4.

DOI:10.1038/s41401-020-0380-z
PMID:32132659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7468250/
Abstract

Motor control in the striatum is an orchestra played by various neuronal populations. Loss of harmony due to dopamine deficiency is considered the primary pathological cause of the symptoms of Parkinson's disease (PD). Recent progress in experimental approaches has enabled us to examine the striatal circuitry in a much more comprehensive manner, not only reshaping our understanding of striatal functions in movement regulation but also leading to new opportunities for the development of therapeutic strategies for treating PD. In addition to dopaminergic innervation, giant aspiny cholinergic interneurons (ChIs) within the striatum have long been recognized as a critical node for balancing dopamine signaling and regulating movement. With the roles of ChIs in motor control further uncovered and more specific manipulations available, striatal ChIs and their corresponding receptors are emerging as new promising therapeutic targets for PD. This review summarizes recent progress in functional studies of striatal circuitry and discusses the translational implications of these new findings for the treatment of PD.

摘要

纹状体中的运动控制是由各种神经元群体演奏的管弦乐。由于多巴胺缺乏导致的和谐丧失被认为是帕金森病 (PD) 症状的主要病理原因。实验方法的最新进展使我们能够更全面地检查纹状体回路,不仅重塑了我们对纹状体在运动调节中的功能的理解,而且为开发治疗 PD 的治疗策略提供了新的机会。除了多巴胺能神经支配外,纹状体内的巨大无棘胆碱性中间神经元 (ChIs) 长期以来一直被认为是平衡多巴胺信号和调节运动的关键节点。随着 ChIs 在运动控制中的作用进一步被揭示,并且有了更具体的操作手段,纹状体 ChIs 及其相应的受体作为 PD 的新的有前途的治疗靶点正在出现。这篇综述总结了纹状体回路功能研究的最新进展,并讨论了这些新发现对治疗 PD 的转化意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de41/7656636/5fa8faf4a068/41401_2020_380_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de41/7656636/4c74198a56bb/41401_2020_380_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de41/7656636/5fa8faf4a068/41401_2020_380_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de41/7656636/4c74198a56bb/41401_2020_380_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de41/7656636/5fa8faf4a068/41401_2020_380_Fig2_HTML.jpg

相似文献

1
Targeting the cholinergic system in Parkinson's disease.针对帕金森病中的胆碱能系统。
Acta Pharmacol Sin. 2020 Apr;41(4):453-463. doi: 10.1038/s41401-020-0380-z. Epub 2020 Mar 4.
2
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.胆碱能中间神经元对帕金森病纹状体病理生理学的贡献。
Neurochem Int. 2019 Jun;126:1-10. doi: 10.1016/j.neuint.2019.02.019. Epub 2019 Feb 27.
3
Striatal cholinergic interneurons and Parkinson's disease.纹状体胆碱能中间神经元与帕金森病。
Eur J Neurosci. 2018 May;47(10):1148-1158. doi: 10.1111/ejn.13638. Epub 2017 Jul 20.
4
A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia.帕金森病和 L-DOPA 诱导性运动障碍中胆碱能中间神经元的新观点。
Neurosci Biobehav Rev. 2018 Sep;92:67-82. doi: 10.1016/j.neubiorev.2018.05.021. Epub 2018 May 18.
5
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.纹状体胆碱能中间神经元以及M1和M4毒蕈碱受体在帕金森病运动症状中的作用
J Neurosci. 2016 Aug 31;36(35):9161-72. doi: 10.1523/JNEUROSCI.0873-16.2016.
6
Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.胆碱能控制纹状体神经元以调节左旋多巴诱导的运动障碍。
Eur J Neurosci. 2019 Mar;49(6):859-868. doi: 10.1111/ejn.14048. Epub 2018 Jul 21.
7
What's wrong with the striatal cholinergic interneurons in Parkinson's disease? Focus on intrinsic excitability.帕金森病纹状体胆碱能中间神经元出了什么问题?聚焦于内在兴奋性。
Eur J Neurosci. 2021 Apr;53(7):2100-2116. doi: 10.1111/ejn.14742. Epub 2020 May 2.
8
Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.帕金森病跌倒大鼠模型中的复杂运动控制:纹状体胆碱能中间神经元的双向控制。
J Neurosci. 2020 Jul 29;40(31):6049-6067. doi: 10.1523/JNEUROSCI.0220-20.2020. Epub 2020 Jun 18.
9
Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease.多巴胺缺乏症降低帕金森病模型纹状体胆碱能中间神经元功能。
Neuron. 2019 Sep 25;103(6):1056-1072.e6. doi: 10.1016/j.neuron.2019.06.013. Epub 2019 Jul 16.
10
Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice.纹状体胆碱能中间神经元调节部分多巴胺耗竭小鼠的认知和情感功能障碍。
Eur J Neurosci. 2018 Nov;48(9):2988-3004. doi: 10.1111/ejn.14153. Epub 2018 Oct 8.

引用本文的文献

1
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson's Disease.α7-烟碱型乙酰胆碱受体在帕金森病病理生理学及治疗中的作用
Int J Mol Sci. 2025 Mar 30;26(7):3210. doi: 10.3390/ijms26073210.
2
Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease.中枢胆碱能神经系统在帕金森病运动和非运动症状中的作用
Curr Neuropharmacol. 2025;23(10):1232-1248. doi: 10.2174/011570159X368923250313045859.
3
Role of Glial Cells and Receptors in Schizophrenia Pathogenesis.

本文引用的文献

1
Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models.胆碱能中间神经元放大帕金森病模型中丘脑纹状体兴奋对纹状体间接通路神经元的兴奋。
Neuron. 2019 Feb 6;101(3):444-458.e6. doi: 10.1016/j.neuron.2018.12.004. Epub 2019 Jan 15.
2
Dopamine Cells Differentially Regulate Striatal Cholinergic Transmission across Regions through Corelease of Dopamine and Glutamate.多巴胺细胞通过多巴胺和谷氨酸的共释放差异调节纹状体胆碱能传递跨越区域。
Cell Rep. 2018 Dec 11;25(11):3148-3157.e3. doi: 10.1016/j.celrep.2018.11.053.
3
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.
神经胶质细胞和受体在精神分裂症发病机制中的作用。
Neurochem Res. 2025 Jan 27;50(2):85. doi: 10.1007/s11064-025-04336-8.
4
Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice.增强纹状体乙酰胆碱可促进帕金森病小鼠的多巴胺释放和纹状体输出。
Cell Biosci. 2024 Dec 3;14(1):146. doi: 10.1186/s13578-024-01328-z.
5
Role of the globus pallidus in motor and non-motor symptoms of Parkinson's disease.苍白球在帕金森病运动和非运动症状中的作用。
Neural Regen Res. 2025 Jun 1;20(6):1628-1643. doi: 10.4103/NRR.NRR-D-23-01660. Epub 2024 Jun 3.
6
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease.神经胶质细胞烟碱型乙酰胆碱受体作为帕金森病的分子靶点。
Cells. 2024 Mar 7;13(6):474. doi: 10.3390/cells13060474.
7
The mechanistic effects of acupuncture in rodent neurodegenerative disease models: a literature review.针刺对啮齿动物神经退行性疾病模型的作用机制:文献综述
Front Neurosci. 2024 Mar 4;18:1323555. doi: 10.3389/fnins.2024.1323555. eCollection 2024.
8
Role of HCN channels in the functions of basal ganglia and Parkinson's disease.HCN 通道在基底神经节功能和帕金森病中的作用。
Cell Mol Life Sci. 2024 Mar 13;81(1):135. doi: 10.1007/s00018-024-05163-w.
9
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions.外显子组在神经退行性疾病中的作用:最新见解和未来方向。
Ann Neurol. 2024 Apr;95(4):635-652. doi: 10.1002/ana.26897. Epub 2024 Feb 27.
10
Assessment of the neuroprotective effect of green synthesized iron oxide nanoparticles capped with curcumin against a rat model of Parkinson's disease.评估姜黄素包覆的绿色合成氧化铁纳米颗粒对帕金森病大鼠模型的神经保护作用。
Iran J Basic Med Sci. 2024;27(1):81-89. doi: 10.22038/IJBMS.2023.73124.15892.
帕金森病的治疗策略:超越多巴胺能药物
Nat Rev Drug Discov. 2018 Nov;17(11):844. doi: 10.1038/nrd.2018.184. Epub 2018 Oct 12.
4
Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.帕金森病:生物标志物、治疗方法及风险因素
Front Neurosci. 2018 Aug 30;12:612. doi: 10.3389/fnins.2018.00612. eCollection 2018.
5
A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia.帕金森病和 L-DOPA 诱导性运动障碍中胆碱能中间神经元的新观点。
Neurosci Biobehav Rev. 2018 Sep;92:67-82. doi: 10.1016/j.neubiorev.2018.05.021. Epub 2018 May 18.
6
New approaches for brain repair-from rescue to reprogramming.新的大脑修复方法——从挽救到重编程。
Nature. 2018 May;557(7705):329-334. doi: 10.1038/s41586-018-0087-1. Epub 2018 May 16.
7
Pauses in Cholinergic Interneuron Activity Are Driven by Excitatory Input and Delayed Rectification, with Dopamine Modulation.胆碱能中间神经元活动的停顿由兴奋性输入和延迟整流驱动,并受多巴胺调制。
Neuron. 2018 Jun 6;98(5):918-925.e3. doi: 10.1016/j.neuron.2018.04.027. Epub 2018 May 10.
8
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations.帕金森病的疾病修饰:当前方法、挑战和未来考虑。
Mov Disord. 2018 May;33(5):660-677. doi: 10.1002/mds.27360. Epub 2018 Apr 11.
9
Dopamine neuron activity before action initiation gates and invigorates future movements.在行动发起前,多巴胺神经元活动会对未来的运动进行“把关”并提供动力。
Nature. 2018 Feb 8;554(7691):244-248. doi: 10.1038/nature25457. Epub 2018 Jan 31.
10
Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites.多巴胺分泌是由稀疏的活性区样释放位点介导的。
Cell. 2018 Feb 8;172(4):706-718.e15. doi: 10.1016/j.cell.2018.01.008. Epub 2018 Feb 1.